Aims. A flexed knee gait is common in patients with bilateral spastic
cerebral palsy and occurs with increased age. There is a risk for
the recurrence of a flexed knee gait when treated in childhood,
and the aim of this study was to investigate whether multilevel
procedures might also be undertaken in adulthood. Patients and Methods. At a mean of 22.9 months (standard deviation 12.9), after single
event multi level surgery, 3D gait analysis was undertaken pre-
and post-operatively for 37 adult patients with bilateral cerebral
palsy and a fixed knee gait. Results. There was a significant improvement of indices and clinical and
kinematic parameters including extension of the hip and knee, reduction
of knee flexion at initial contact, reduction of minimum and mean
knee flexion in the stance phase of gait, improved range of movement
of the knee and a reduction of mean flexion of the hip in the stance phase.
Genu recurvatum occurred in two patients (n = 3 legs, 4%) and an
increase of pelvic tilt (>
5°) was found in 12 patients (n = 23
legs, 31%). Conclusion. Adult patients with bilateral
Purpose. The incidence of hip displacement in children with
Children with diplegic
Intramuscular injections of botulinum neuro toxin A (BoNT-A) have been a cornerstone in the treatment of spasticity for the last two decades. In India, the treatment is now offered to children with spastic
Children with
Purpose. The authors have used the Edinburgh Visual Gait Score (VGS) in the management of diplegic
To assess long and short term kinematic gait outcomes after rectus femoris transfers (RFT) in ambulatory children with
Introduction. Some patients with
Scoliosis is estimated to occur between 21–64% of patients with
Aim. In an earlier study we identified severe Vitamin D deficiency as a problem in institutionalised children with
Proximal femoral deformity is common in children with
Hip displacement is the second most common deformity in children with
Aim. To assess the risk of hip dislocations in children with
In order to manage painful subluxation/dislocation secondary to
Aims. Single-event multilevel surgery (SEMLS) has been used as an effective
intervention in children with bilateral spastic
Introduction. Hip dysplasia is the most common congenital deformity of the musculoskeletal system. This is a pathology that brings the hip joint from subluxation to dislocation. Frequency of hip dysplasia − 16 children per 1000 newborns. Materials and Methods. Diagnostic methods of research are X-ray inspection which is necessarily carried out at internal rotation (rotation) of an extremity as lateral rotation of a hip on the radiograph always increases an angle of a valgus deviation of a neck. Surgical treatment is performed in the subclavian area of the femur. An external fixation device is applied and a corrective corticotomy is performed, and valgus deformity and anteversion are eliminated. The duration of treatment is 2.5–3 months. Results. Frequency of hip dysplasia − 16 children per 1000 newborns. We perform about 30 operations a year, including 60% girls and 40% boys. In addition, valgus deformity can be traced -. - in
There has been a reluctance, until relatively recently, to consider replacement of the hip in patients with substantial neuromuscular imbalance. This relates to many factors, including the young age of many (such as
The use of total hip arthroplasty in adolescents for end-stage degenerative hip disease is controversial with few reported outcomes in the literature. The purpose of the study was to report the outcomes of total hip arthroplasty in a cohort of adolescents managed by a multidisciplinary team of paediatric and adult orthopaedic surgeons from a single centre. A multidisciplinary clinic consisting of paediatric and adult hip surgeons was established in 2013 to identify, treat and prospectively follow adolescents who would potentially beneift from a total hip arthoplasty. To date 29 consecutive adolescent patients (20 female, 9 male, 32 hips) with end stage degenerative hip disease have undergone cementless primary total hip arthroplasty. Mean age at decision to treat was 15.7 years (age 11.4–18.5). Ten different underlying paediatric specific pathologies were documented including DDH,